POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Brazil approves definitive use of Pfizer virus vaccine

Christian Fernsby |
Brazil’s health regulator, Anvisa, approved a definitive use of the coronavirus vaccine Tuesday developed by Pfizer and BioNTech.

Article continues below




The decision came more than two weeks after Pfizer applied to Anvisa for permission on Feb 6.

"The immunizer from the Pfizer/BioNTech Laboratory had its safety, quality, and efficacy, assessed and certified by the technical team of Anvisa that continues its work to protect the health of the Brazilian citizens," Anvisa said in a statement.

The Chinese CoronaVac and Oxford's AstraZeneca from the UK are among vaccines that have emergency use authorization in Brazil.

The South American nation is the worst-hit by the pandemic on the continent and has the third-highest case tally globally, according to US-based Johns Hopkins University. It has recorded nearly 10.2 million infections and fatalities near 250,000.


What to read next

DNA-based vaccine guards against Zika in monkey study
U.S. starts coronavirus vaccine rollout
FDA issues emergency use authorization for first U.S. coronavirus vaccine